Morning briefing: Blackstone flips Hipgnosis songs catalogues for up to $4bn; International Biotechnology scores 39% half-year return; plus Workspace, Ceiba Investments, Ecofin US Renewables, Home REIT, Augmentum Fintech
Blackstone has sold the 45,000 song Hipgnosis catalogue to Sony in a deal reported to be up to $4bn. The music rights business, renamed Recognition Music Group last year, includes former London-listed Hipgnosis Songs Fund which Blackstone took private with a $1.57bn bid in 2024. Singapore wealth fund GIC is backing Sony.
The rebound in International Biotechnology Trust (IBT) saw the £521m fund beat its 29.5% benchmark return with a 35.7% investment return that underpinned a 39% return for shareholders in the half year to 28 February. The period was notable for a recovery in mergers and acquisitions with five portfolio companies falling to bids. These were: 89bio, Metsera, Merus, Akera Therapeutics and Avidity Biosciences.
James Carthew, head of investment company research at QuotedData, said: “After a prolonged slump, it is great to see the rebound in the biotech sector, and as a shareholder I have been delighted by the returns being generated by International Biotechnology. As it makes clear, these haven’t just come from takeovers, clinical successes have been a big driver, too. There is no shortage of innovation in the medical field and demand for healthcare continues to grow, supported by demographic trends. Even if we see a pause for breath after the recent dramatic rise, the long term outlook for this sector is as healthy as ever.”
Saba Capital has lifted its stake in Workspace (WKP) to almost 20% from 18.2% as the activist hedge fund strengthens its position in the office real estate investment trust ahead of the annual general meeting on 23 July when it will seek to remove five of the six directors on its board.
Ceiba Investments (CBA), the £40m Cuban commercial property fund, has raised £10.4m from a new strategic investor which will hold a 16.7% stake, giving the company funds to pay €5m due to its bond holders plus fees to its former fund manager Aberdeen Group. The new investor bought 27.5m new shares at 38p, a 31% premium to the ordinary share price at 8 May but 39.8% below their net asset value of 63.1p at 31 December.
Ecofin US Renewables (RNEW) has confirmed the launch of a B-share issue that will return $10m to shareholders on Friday 15 May. The shares will be issued at no cost on a one-for-one basis and immediately redeemed at $1. This will distribute most of the initial tranche RNEW received in the $30m sale of Whirlwind, the Texas wind farm that previously made up around a third of the portfolio.
Arena Investors, the New York-based special situations fund we highlighted buying shares in Home Reit (HOME) last week, has lifted its stake to 6.3% from 5.1%. Activists Staude Capital and AVI have also disclosed 9% and 5.8% positions in the former homeless accommodation provider that returned from a 39-month suspension on 29 April.
Augmentum Fintech (AUGM) has received High Court approval for its £185.7m takeover by Norway’s Verdane. The acquisition will become effective when the court order is delivered to the Registrar of Companies tomorrow.
Stay a step ahead. Our daily newsletter brings you the latest on investment trusts and active ETFs. Subscribe here.